Cargando…
MPC-06 LRG1 HAS MULTIPLE POTENTIAL FOR CLINICOPATHOLOGICAL BIOMARKER OF GLIOBLASTOMA
BACKGROUND AND AIM: Leucine-rich α-2 glycoprotein 1 (LRG1) is one of the candidate proteins as a diagnostic marker for glioblastoma. Although association with angiogenesis has been reported, it has been suggested that the role as a biomarker differs depending on the tumor types. The role of LRG1 as...
Autores principales: | Furuta, Takuya, Sugita, Yasuo, Komaki, Satoru, Ohshima, Kouichi, Morioka, Motohiro, Uchida, Yasuo, Tachikawa, Masanori, Otsuki, Sumio, Terasaki, Tetsuya, Nakada, Mitsutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213456/ http://dx.doi.org/10.1093/noajnl/vdz039.103 |
Ejemplares similares
-
Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics
por: Miyauchi, Eisuke, et al.
Publicado: (2018) -
CS-7 A case of Lymphomatoid granulomatosis with skin, lung, and intracranial lesions due to multicentric development
por: Komaki, Satoru, et al.
Publicado: (2021) -
Pituitary Gangliocytoma Producing TSH and TRH: A Review of “Gangliocytomas of the Sellar Region”
por: Sakata, Kiyohiko, et al.
Publicado: (2020) -
Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas
por: Komaki, Satoru, et al.
Publicado: (2019) -
Attenuation of prostaglandin E(2 )elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole
por: Akanuma, Shin-ichi, et al.
Publicado: (2011)